Grissinger Michael bought LPCN
August 3, 2026 · Form 4 insider transaction
Grissinger Michael bought 2,000 shares of Lipocine Inc. at $2.11 per share, a transaction worth $4.2K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,000
Price
$2.11
Total value
$4.2K
InsiderGrissinger Michael
RoleDirector
CompanyLipocine Inc. (LPCN)
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateAugust 3, 2026
Filing dateAugust 7, 2026
Shares owned after2,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of August 3, 2027, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorata basis over the following two years.